SavedAdd your journal

Journals / Türk Nöroloji Dergisi / 2016 / Cilt: 22 - Sayı: 1

The Acute Treatment of Migraine Attack in Adults and American Headache Society Evidence Assessment of Migraine Pharmacotherapies

Erişkinlerde Akut Migren Atağının Tedavisi ve Amerikan Baş Ağrısı Derneği Migren Farmakoterapisi Kanıt Değerlendirmesi

Pınar Yalınay DİKMEN
Pages
3–7
Publication Date
2022-11-04
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

This review primarily reminds clinical pearls in acute treatment of migraine and also summarizes the American Headache Society Evidence Assessment of Migraine Pharmacotherapies that published last year.

📌 3 Key Takeaways

🎯
Objective & Hypothesis:Migraine is a common, the primary debilitating and recurring headache disorder.
📊
Key Findings & Data:The main purpose migraine acute pharmacology is to reduce the impact and disability caused by the attack of migraine.
💡
Conclusion & Impact:This review primarily reminds clinical pearls in acute treatment of migraine and also summarizes the American Headache Society Evidence Assessment of Migraine Pharmacotherapies that published last year.
🔬Design:Review & Systematic Survey
📍Scope:Comprehensive Sample
⚙️Variables:Domain Parameters

Abstract

Migraine is a common, the primary debilitating and recurring headache disorder. The main purpose migraine acute pharmacology is to reduce the impact and disability caused by the attack of migraine. This review primarily reminds clinical pearls in acute treatment of migraine and also summarizes the American Headache Society Evidence Assessment of Migraine Pharmacotherapies that published last year.

Özet

Migren sık görülen, kısıtlılık yaratan ve tekrarlayıcı birincil baş ağrısı hastalığıdır. Migren atak tedavisinin temel amacı migren atağının etkisini ve yarattığı kısıtlılığı azaltmaktır. Bu gözden geçirme öncelikle migrenin akut tedavisindeki klinik tavsiyeleri hatırlatmakta ve geçen yıl yayınlanan Amerikan Baş Ağrısı Derneği Migren Farmakoterapisi'nde Kanıt Değerlendirmesi özetlenmektedir.

🔖

Cite This Article

DİKMEN, P. Y. (2022). The Acute Treatment of Migraine Attack in Adults and American Headache Society Evidence Assessment of Migraine Pharmacotherapies. Türk Nöroloji Dergisi, Cilt: 22 - Sayı: 1, 3–7. https://ajindex.com/articles/636907

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (12)

  1. Stewart WF, Lipton RB, Celentano DD, Reed ML. Prevalence of migraine headache in the United States. Relation to age, income, race and other sociodemographic factors. JAMA 1992;267:64-69
  2. Headache classification of the International Headache Society. The International Classification of Headache Disorders, 3rd edition (beta version). Cephalalgia 2013;33:627-808
  3. Buse DC, Manack AN, Fanning KM, Serrano D, Read ML, Turkel CC, Lipton RB. Chronic migraine prevalence, disability, and sociodermographic factors: Results from the American Migraine Prevalence and Prevention Study. Headache 2012;53:1456-1470
  4. Silberstein S, Loder E, Diamond S, Reed ML, Bigal ME, Lipton RB, with the AMPP Advisory Group. Probable migraine in the United States: Results of the American Migraine Prevalence and Prevention Study. Cephalalgia 2007;27:220-229
  5. Diamond S, Bigal ME, Silberstein S, Loder E, Reed M, Lipton RB. Patterns of diagnosis and acute and preventive treatment for migraine in the United States: Results of the American Migraine Prevalence and Prevention Study. Headache 2007;47:355-363
  6. Marmura JM, Silberstein SD, Schwedt TJ. The Acute Treatment of Migraine in Adults: The American Headache Society Evidence Assessment of Migraine Pharmacotherapies. Headache 2015;55:3-20
  7. Lipton RB, Stewart WF, Stone AM, Lainez MJ, Sawyer JP; Disability in Strategies of Care Study group. Stratified care vs step care strategies for migraine: The Disability in Strategies of Care (DISC) Study: A randomized trial. JAMA. 2000;284:2599-2605
  8. Sculpher M, Millson D, Meddis D, Poole L. Cost-effectiveness analysis of stratified versus stepped care strategies for acute treatment of migraine: The Disability in Strategies of Care (DISC) Study. Pharmacoeconomics. 2002;20:91-100
  9. Bigal ME, Serrano D, Buse D, Scher A, Stewart WF, Lipton RB. Acute migraine medications and evolution from episodic to chronic migraine: A longitudinal population-based study. Headache 2008;48:1157- 1168
  10. McGettigan P, Henry D. Cardiovascular risk and inhibition of cyclooxygenase: A systematic review of the observational studies of selective and nonselective inhibitors of cyclooxygenase 2. JAMA 2006;296:1633-1644
  11. Silberstein SD. Practice parameter- Evidence-based guidelines for migraine headache (an evidence-based-review): Report of the quality standards Subcommittee of the American Academy of Neurology fort he United States Headache Consortium. Neurology 2000;55:754- 762
  12. Tfelt-Hansen P, Pascua